82 related articles for article (PubMed ID: 21439273)
1. POTEH hypomethylation, a new epigenetic biomarker for glioma prognosis.
Liu X; Tang H; Zhang Z; Li W; Wang Z; Zheng Y; Wu M; Li G
Brain Res; 2011 May; 1391():125-31. PubMed ID: 21439273
[TBL] [Abstract][Full Text] [Related]
2. F10 gene hypomethylation, a putative biomarker for glioma prognosis.
Liu X; Tang H; Wang Z; Huang C; Zhang Z; She X; Wu M; Li G
J Neurooncol; 2012 May; 107(3):479-85. PubMed ID: 22160665
[TBL] [Abstract][Full Text] [Related]
3. Promoter hypermethylation-mediated inactivation of LRRC4 in gliomas.
Zhang Z; Li D; Wu M; Xiang B; Wang L; Zhou M; Chen P; Li X; Shen S; Li G
BMC Mol Biol; 2008 Nov; 9():99. PubMed ID: 18976507
[TBL] [Abstract][Full Text] [Related]
4. CpG hypomethylation of MDR1 gene in tumor and serum of invasive ductal breast carcinoma patients.
Sharma G; Mirza S; Parshad R; Srivastava A; Datta Gupta S; Pandya P; Ralhan R
Clin Biochem; 2010 Mar; 43(4-5):373-9. PubMed ID: 19879256
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas.
Brell M; Tortosa A; Verger E; Gil JM; Viñolas N; Villá S; Acebes JJ; Caral L; Pujol T; Ferrer I; Ribalta T; Graus F
Clin Cancer Res; 2005 Jul; 11(14):5167-74. PubMed ID: 16033832
[TBL] [Abstract][Full Text] [Related]
6. p16 promoter methylation in the serum as a basis for the molecular diagnosis of gliomas.
Wakabayashi T; Natsume A; Hatano H; Fujii M; Shimato S; Ito M; Ohno M; Ito S; Ogura M; Yoshida J
Neurosurgery; 2009 Mar; 64(3):455-61; discussion 461-2. PubMed ID: 19240607
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylation of the RASSF1A gene in gliomas.
Gao Y; Guan M; Su B; Liu W; Xu M; Lu Y
Clin Chim Acta; 2004 Nov; 349(1-2):173-9. PubMed ID: 15469871
[TBL] [Abstract][Full Text] [Related]
8. Expression of CRM1 in human gliomas and its significance in p27 expression and clinical prognosis.
Shen A; Wang Y; Zhao Y; Zou L; Sun L; Cheng C
Neurosurgery; 2009 Jul; 65(1):153-9; discussion 159-60. PubMed ID: 19574837
[TBL] [Abstract][Full Text] [Related]
9. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
[TBL] [Abstract][Full Text] [Related]
10. MGMT as a potential stratification marker in relapsed high-grade glioma of children: the HIT-GBM experience.
Schlosser S; Wagner S; Mühlisch J; Hasselblatt M; Gerss J; Wolff JE; Frühwald MC
Pediatr Blood Cancer; 2010 Feb; 54(2):228-37. PubMed ID: 19856394
[TBL] [Abstract][Full Text] [Related]
11. Relationship between methylation status of ERCC1 promoter and radiosensitivity in glioma cell lines.
Liu ZG; Chen HY; Cheng JJ; Chen ZP; Li XN; Xia YF
Cell Biol Int; 2009 Oct; 33(10):1111-7. PubMed ID: 19664717
[TBL] [Abstract][Full Text] [Related]
12. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival.
Zagzag D; Blanco C; Friedlander DR; Miller DC; Newcomb EW
Hum Pathol; 2003 Jan; 34(1):48-53. PubMed ID: 12605366
[TBL] [Abstract][Full Text] [Related]
13. [Application of diffusion tensor imaging in preoperation and postoperation patients of glioma with 3.0 Tesla MRI].
Li X; Yu RT; Xu K; Li FC; Fan YC; Gao WC; Guo KQ; Pan X; Yang C
Zhonghua Yi Xue Za Zhi; 2009 May; 89(19):1300-4. PubMed ID: 19615179
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor expression and gene amplification in high-grade non-brainstem gliomas of childhood.
Bredel M; Pollack IF; Hamilton RL; James CD
Clin Cancer Res; 1999 Jul; 5(7):1786-92. PubMed ID: 10430083
[TBL] [Abstract][Full Text] [Related]
15. Careful exclusion of non-neoplastic brain components is required for an appropriate evaluation of O6-methylguanine-DNA methyltransferase status in glioma: relationship between immunohistochemistry and methylation analysis.
Sasai K; Nodagashira M; Nishihara H; Aoyanagi E; Wang L; Katoh M; Murata J; Ozaki Y; Ito T; Fujimoto S; Kaneko S; Nagashima K; Tanaka S
Am J Surg Pathol; 2008 Aug; 32(8):1220-7. PubMed ID: 18580490
[TBL] [Abstract][Full Text] [Related]
16. TP53 promoter methylation in human gliomas.
Amatya VJ; Naumann U; Weller M; Ohgaki H
Acta Neuropathol; 2005 Aug; 110(2):178-84. PubMed ID: 16025287
[TBL] [Abstract][Full Text] [Related]
17. Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer.
Saito K; Kawakami K; Matsumoto I; Oda M; Watanabe G; Minamoto T
Clin Cancer Res; 2010 Apr; 16(8):2418-26. PubMed ID: 20371677
[TBL] [Abstract][Full Text] [Related]
18. Expression of PINCH protein in gliomas and its clinicopathological significance.
Wang MW; Gu P; Zhang ZY; Zhu ZL; Li YM; Zhao HX; Sun XF
Oncology; 2007; 72(5-6):343-6. PubMed ID: 18187956
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of CCAAT/enhancer binding protein beta correlates with prognosis in glioma patients.
Homma J; Yamanaka R; Yajima N; Tsuchiya N; Genkai N; Sano M; Tanaka R
Oncol Rep; 2006 Mar; 15(3):595-601. PubMed ID: 16465418
[TBL] [Abstract][Full Text] [Related]
20. [Expression of cyclin D1 in brain gliomas and its significance].
Tan PG; Xing Z; Li ZQ
Ai Zheng; 2004 Jan; 23(1):63-5. PubMed ID: 14720377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
